GlobalData on MSN1 个月
FDA AdCom votes in favour of Stealth’s Barth syndrome drug
A US Food and Drug Administration (FDA) advisory committee (AdCom) has voted in support of Stealth Biotherapeutics’ ...
Medpage Today on MSN1 个月
Elamipretide for Barth Syndrome Survives FDA Advisory Vote
FDA advisors indicated a possible path forward for elamipretide as a treatment for Barth syndrome despite the lack of ...